
NanoHive Medical entered into an agreement with Accelus, expanding the distribution network for NanoHive’s Hive™ Soft Titanium® portfolio of interbody fusion devices in the U.S.
Hive spinal implants provide biomechanical elastic modulus properties comparable to PEEK devices, clear diagnostic imaging capability, titanium surface technology that enables osteoblastic cell attraction and integration, and proprietary biologics injection ports. These features are designed to lead to consistently strong fusion constructs and efficacious clinical experiences.
“This exciting collaboration gives surgeons access to our innovative Hive™ Soft Titanium® 3D-printed interbody fusion technology along with Accelus’s innovative product portfolio including their flagship FlareHawk® and TiHawk™ Multidirectional Expanding Interbody Fusion Devices and Remi™ Robotic Navigation System.” said Patrick O’Donnell, President & Chief Executive Officer for NanoHive Medical. “We anticipate the partnership will broaden NanoHive’s market penetration to include the significant volume of spinal fusion procedures migrating from hospital in-patient facilities to out-patient and ambulatory care surgery center facilities.”
Source: NanoHive Medical LLC
JAV
Julie A. Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.